---
layout: post
title: "BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results"
date: 2026-02-23T21:05:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/biomarin-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results-302694181.html
significance: 9.00
---

<p>Full-year 2025 Total Revenues Increased 13% Y/Y to $3.2 Billion, Led by 9% Revenue Growth for Enzyme Therapies and 26% Revenue Growth for VOXZOGOÂ® Fourth Quarter 2025 Total Revenues Increased 17% Y/Y Led by 13% Revenue Growth for Enzyme Therapies and 31% Revenue Growth for VOXZOGO...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/biomarin-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results-302694181.html)

**Published:** 2026-02-23 21:05:00 +0000

**Significance Score:** 9.00

[View original](https://www.prnewswire.com/news-releases/biomarin-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results-302694181.html)
